Published in
Wiley, British Journal of Haematology, 4(194), p. 784-788, 2021
DOI: 10.1111/bjh.17541
Links
Tools
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
Journal article published in 2021 by
Hang Quach 
,
Ajay Nooka,
Olga Samoylova,
Christopher P. Venner,
Kihyun Kim,
Thierry Facon,
Andrew Spencer,
Saad Z. Usmani,
Sebastian Grosicki ,
Kenshi Suzuki,
Sosana Delimpasi,
Katja Weisel,
Mihaela Obreja,
Anita Zahlten‐Kumeli,
Maria‐Victoria Mateos
,
Ajay Nooka,
Olga Samoylova,
Christopher P. Venner,
Kihyun Kim,
Thierry Facon,
Andrew Spencer,
Saad Z. Usmani,
Sebastian Grosicki ,
Kenshi Suzuki,
Sosana Delimpasi,
Katja Weisel,
Mihaela Obreja,
Anita Zahlten‐Kumeli,
Maria‐Victoria Mateos
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 